USFDA Cites Intas Pharma for Manufacturing Lapses
December 10, 2023 10:50
The USFDA issued a warning letter to Intas Pharmaceuticals for manufacturing violations, including CGMP violations, at its Ahmedabad plant. The agency found that the company failed to maintain...